These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 284708)

  • 1. The effect of different sulfonamides on phenytoin metabolism in man.
    Hansen JM; Kampmann JP; Siersbaek-Nielsen K; Lumholtz IB; Arrøe M; Abildgaard U; Skovsted L
    Acta Med Scand Suppl; 1979; 624():106-10. PubMed ID: 284708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [METABOLIC FATE OF DELAYED-ACTION SULFONAMIDES].
    SALVI G; PLANCHER AC
    Farmaco Prat; 1964 Feb; 19():75-83. PubMed ID: 14138309
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulfamethizole-induced inhibition of diphenlhydantoin, tolbutamide, and warfarin metabolism.
    Lumholtz B; Siersbaek-Nielsen K; Skovsted L; Kampmann J; Hansen JM
    Clin Pharmacol Ther; 1975 Jun; 17(6):731-4. PubMed ID: 1139863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
    Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
    Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.
    Komatsu K; Ito K; Nakajima Y; Kanamitsu Si; Imaoka S; Funae Y; Green CE; Tyson CA; Shimada N; Sugiyama Y
    Drug Metab Dispos; 2000 Apr; 28(4):475-81. PubMed ID: 10725317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ANTIBACTERIAL SULFONAMIDES].
    TREFOUEL J
    Prod Probl Pharm; 1964 Jan; 19():3-14. PubMed ID: 14135919
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of sulfonamides by NMR spectroscopy.
    Turczan J; Medwick T
    J Pharm Sci; 1972 Mar; 61(3):434-43. PubMed ID: 5066968
    [No Abstract]   [Full Text] [Related]  

  • 8. Is phenytoin metabolism dose-dependent by enzyme saturation or by feedback inhibition?
    Perucca E; Makki K; Richens A
    Clin Pharmacol Ther; 1978 Jul; 24(1):46-51. PubMed ID: 657718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of sulfonamides and trimethoprim in the donkey (Equus asinus).
    Oukessou M; Alsouss L
    Zentralbl Veterinarmed A; 1998 May; 45(4):191-8. PubMed ID: 9697419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative clinical evaluation of sulfaphenazole, sulfadimethoxine, and sulfamethoxypyridazine.
    FRISH AR; HOLMGARD A
    Antibiot Annu; 1959-1960; 7():868-72. PubMed ID: 13855804
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluative bases for new sulfonamides].
    WALTER AM
    Chemotherapia (Basel); 1963; 6():161-79. PubMed ID: 13998665
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenytoin metabolism in subjects with long and short plasma half-lives.
    Glazko AJ; Peterson FE; Chang T; Dill WA; Smith TC; Buchanan RA
    Ther Drug Monit; 1982; 4(3):281-92. PubMed ID: 7135458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibitory effects of phenytoin, diclofenac, phenylbutazone and a series of sulfonamides on hepatic cytochrome P4502C activity in vitro, and correlation with some molecular descriptors in the dwarf goat (Caprus hircus aegagrus).
    Zweers-Zeilmaker WM; Horbach GJ; Witkamp RF
    Xenobiotica; 1997 Aug; 27(8):769-80. PubMed ID: 9293615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism in sulfonamides.
    Yang SS; Guillory JK
    J Pharm Sci; 1972 Jan; 61(1):26-40. PubMed ID: 5066733
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of sulfonamides by TLC using metal ions.
    Walash MI; Agarwal SP
    J Pharm Sci; 1972 Feb; 61(2):277-8. PubMed ID: 5066790
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenytoin metabolism to 5-(4-hydroxyphenyl)-5-phenylhydantoin (HPPH) in man, cat and rat in vitro and in vivo, and susceptibility to phenytoin-induced gingival overgrowth.
    Kamali F; Ball DE; McLaughlin WS; Seymour RA
    J Periodontal Res; 1999 Apr; 34(3):145-53. PubMed ID: 10384402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.
    Ortengren B; Magni L; Bergan T
    Infection; 1979; 7 Suppl 4():S371-81. PubMed ID: 511351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New sulfonamide derivatives. Comparative study of the absorption and excretion of sulfaphenazole, sulfadimethoxine and sulfamethoxypyridazine].
    FRISK AR; HOLMGARD A
    Nord Med; 1960 Mar; 63():352-4. PubMed ID: 13825264
    [No Abstract]   [Full Text] [Related]  

  • 19. Doses and dosage intervals of drugs--clinical practice and pharmacokinetic principles.
    Boëthius G; Sjöqvist F
    Clin Pharmacol Ther; 1978 Sep; 24(3):255-63. PubMed ID: 28868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COMPARISON OF THE FATE OF VARIOUS PYRIDAZINE SULFONAMIDES IN THE ANIMAL BODY].
    PLACKOVA Z; WAGNER J; HAIS IM
    Cesk Farm; 1963 Jun; 12():239-42. PubMed ID: 14076174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.